Beam Therapeutics, Inc. (BEAM)
29.40
-0.09
(-0.31%)
USD |
NASDAQ |
Jun 11, 16:00
29.48
+0.08
(+0.27%)
After-Hours: 20:00
Beam Therapeutics Accounts Payable (Quarterly) : 12.29M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 12.29M |
| December 31, 2025 | 10.23M |
| September 30, 2025 | 9.545M |
| June 30, 2025 | 10.56M |
| March 31, 2025 | 7.699M |
| December 31, 2024 | 3.871M |
| September 30, 2024 | 3.812M |
| June 30, 2024 | 4.429M |
| March 31, 2024 | 2.79M |
| December 31, 2023 | 1.617M |
| September 30, 2023 | 3.177M |
| June 30, 2023 | 6.886M |
| March 31, 2023 | 14.06M |
| December 31, 2022 | 9.029M |
| September 30, 2022 | 7.024M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.095M |
| March 31, 2022 | 6.266M |
| December 31, 2021 | 7.474M |
| September 30, 2021 | 7.282M |
| June 30, 2021 | 8.03M |
| March 31, 2021 | 7.983M |
| December 31, 2020 | 6.314M |
| September 30, 2020 | 6.569M |
| June 30, 2020 | 6.154M |
| March 31, 2020 | 6.101M |
| December 31, 2019 | 7.846M |
| September 30, 2019 | 3.857M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 7.351M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 18.80M |
| Twist Bioscience Corp. | 14.68M |
| Caribou Biosciences, Inc. | 3.503M |
| Arrowhead Pharmaceuticals, Inc. | 30.75M |
| Oncolytics Biotech, Inc. | 0.00 |